Display options
Share it on

Pediatr Blood Cancer. 2021 Aug;68(8):e29130. doi: 10.1002/pbc.29130. Epub 2021 May 27.

Impact of executive functioning on health-related quality of life of pediatric brain tumor survivors.

Pediatric blood & cancer

Camara Murphy, Naadira C Upshaw, Amanda S Thomas, Grace Fong, Anna Janss, Claire Mazewski, Lisa M Ingerski

Affiliations

  1. Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.
  2. Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, Georgia, USA.

PMID: 34047487 DOI: 10.1002/pbc.29130

Abstract

BACKGROUND: Brain tumor survivors are at risk for significant late effects following treatment completion that may adversely impact health-related quality of life (HRQOL). The current study examines the relationship between executive functioning (EF) and HRQOL in pediatric brain tumor survivors within a longitudinal framework. We hypothesized that early deficits in EF would be related to less optimal HRQOL in this population.

PROCEDURE: The current study utilized retrospective medical chart review to identify neurocognitive correlates of HRQOL in 137 youth previously treated for a pediatric brain tumor. Participants completed the Pediatric Quality of Life Inventory (PedsQL) and neuropsychological assessment, including a well-validated measure of executive functioning (Behavior Rating Inventory of Executive Function; BRIEF). General linear regression and multivariate models were utilized to examine the relationship between child executive functioning and HRQOL.

RESULTS: Multiple domains of child executive functioning, as reported by parents on the BRIEF, significantly predicted parent-proxy reported HRQOL after controlling for demographic and medical covariates, including child intellectual functioning (IF). Similarly, after controlling for covariates, the BRIEF Cognitive Regulation Index was a significant predictor of self-reported physical and school functioning domains of HRQOL.

CONCLUSION: Current data demonstrate EF is a significant predictor of HRQOL during survivorship for youth previously diagnosed with a pediatric brain tumor. Results suggest that opportunities may exist to intervene and improve HRQOL of pediatric brain tumor survivors by targeting EF.

© 2021 Wiley Periodicals LLC.

Keywords: executive functioning; health-related quality of life; pediatric brain tumor; survivorship

References

  1. American Cancer Society. Facts & Figures. 2018. Atlanta, GA: American Cancer Society; 2018. - PubMed
  2. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69:7-34. - PubMed
  3. Fuemmeler BF, Elkin TD, Mullins LL. Survivors of childhood brain tumors: behavioral, emotional, and social adjustment. Clin Psychol Rev. 2002;22:547-585. - PubMed
  4. Hudson MM, Ness KK, Gurney JG, et al. Clinical ascertainment of health outcomes among adults treated for childhood cancer. JAMA. 2013;309:2371-2381. - PubMed
  5. Piscione PJ, Bouffet E, Mabbott DJ, Shams I, Kulkarni AV. Physical functioning in pediatric survivors of childhood posterior fossa brain tumors. Neuro Oncol. 2014;16:147-155. - PubMed
  6. Vinchon M, Baroncini M, Leblond P, Delestret I. Morbidity and tumor-related mortality among adult survivors of pediatric brain tumors: a review. Childs Nerv Syst. 2011;27:697-704. - PubMed
  7. Beebe DW, Ris MD, Armstrong FD, et al. Cognitive and adaptive outcome in low-grade pediatric cerebellar astrocytomas: evidence of diminished cognitive and adaptive functioning in national collaborative research studies (CCG 9891/POG 9130). J Clin Oncol. 2005;23:5198-5204. - PubMed
  8. Chevignard M, Câmara-Costa H, Doz F, Dellatolas G. Core deficits and quality of survival after childhood medulloblastoma: a review. Neurooncol Pract. 2017;4:82-97. - PubMed
  9. Edelstein K, Spiegler BJ, Fung S, et al. Early aging in adult survivors of childhood medulloblastoma: long-term neurocognitive, functional, and physical outcomes. Neuro Oncol. 2011;13:536-545. - PubMed
  10. Vance YH, Eiser C, Horne B. Parents’ views of the impact of childhood brain tumours and treatment on young people's social and family functioning. Clin Child Psychol Psychiatry. 2004;9:271-288. - PubMed
  11. Grill J, Renaux VK, Bulteau C, et al. Long-term intellectual outcome in children with posterior fossa tumors according to radiation doses and volumes. Int J Radiat Oncol Biol Phys. 1999;45:137-145. - PubMed
  12. Hanzlik E, Woodrome SE, Abdel-Baki M, Geller TJ, Elbabaa SK. A systematic review of neuropsychological outcomes following posterior fossa tumor surgery in children. Childs Nerv Syst. 2015;31:1869-1875. - PubMed
  13. Lannering B, Marky I, Lundberg A, Olsson E. Long-term sequelae after pediatric brain tumors: their effect on disability and quality of life. Med Pediatr Oncol. 1990;18:304-310. - PubMed
  14. Ris MD, Walsh K, Wallace D, et al. Intellectual and academic outcome following two chemotherapy regimens and radiotherapy for average-risk medulloblastoma: COG A9961. Pediatr Blood Cancer. 2013;60:1350-1357. - PubMed
  15. Spiegler BJ, Bouffet E, Greenberg ML, Rutka JT, Mabbott DJ. Change in neurocognitive functioning after treatment with cranial radiation in childhood. J Clin Oncol. 2004;22:706-713. - PubMed
  16. Margelisch K, Studer M, Ritter BC, Steinlin M, Leibundgut K, Heinks T. Cognitive dysfunction in children with brain tumors at diagnosis. Pediatr Blood Cancer. 2015;62:1805-1812. - PubMed
  17. Poggi G, Liscio M, Galbiati S, et al. Brain tumors in children and adolescents: cognitive and psychological disorders at different ages. Psychooncology. 2005;14:386-395. - PubMed
  18. Dehorter N, Vinay L, Hammond C, Ben-Ari Y. Timing of developmental sequences in different brain structures: physiological and pathological implications. Eur J Neurosci. 2012;35:1846-1856. - PubMed
  19. Upton P, Eiser C. School experiences after treatment for a brain tumour. Child Care Health Dev. 2006;32:9-17. - PubMed
  20. Fowler MG, Johnson MP, Atkinson SS. School achievement and absence in children with chronic health conditions. J Pediatr. 1985;106:683-687. - PubMed
  21. Mulhern RK, Hancock J, Fairclough D, Kun L. Neuropsychological status of children treated for brain tumors: a critical review and integrative analysis. Med Pediatr Oncol. 1992;20:181-191. - PubMed
  22. Bellanti CJ, Bierman KL. Disentangling the impact of low cognitive ability and inattention on social behavior and peer relationships. Conduct problems prevention research group. J Clin Child Psychol. 2000;29:66-75. - PubMed
  23. Nassau JH, Drotar D. Social competence among children with central nervous system-related chronic health conditions: a review. J Pediatr Psychol. 1997;22:771-793. - PubMed
  24. Bhat SR, Goodwin TL, Burwinkle TM, et al. Profile of daily life in children with brain tumors: an assessment of health-related quality of life. J Clin Oncol. 2005;23:5493-5500. - PubMed
  25. Netson KL, Ashford JM, Skinner T, et al. Executive dysfunction is associated with poorer health-related quality of life in pediatric brain tumor survivors. J Neurooncol. 2016;128:313-321. - PubMed
  26. Sato I, Higuchi A, Yanagisawa T, et al. Impact of late effects on health-related quality of life in survivors of pediatric brain tumors: motility disturbance of limb(s), seizure, ocular/visual impairment, endocrine abnormality, and higher brain dysfunction. Cancer Nurs. 2014;37:E1-E14. - PubMed
  27. An KJ, Joung YS, Sung KW, Kim J-H. Health-related quality of life and cognitive functioning at on- and off-treatment periods in children aged between 6-13 years old with brain tumors: a prospective longitudinal study. Yonsei Med J. 2013;54:306-314. - PubMed
  28. Hocking MC, Hobbie WL, Deatrick JA, Hardie TL, Barakat LP. Family functioning mediates the association between neurocognitive functioning and health-related quality of life in young adult survivors of childhood brain tumors. J Adolesc Young Adult Oncol. 2015;4:18-25. - PubMed
  29. Dessens AB, van Herwerden MC, Aarsen FK, Birnie E, Catsman-Berrevoets CE. Health-related quality of life and emotional problems in children surviving brain tumor treatment: a descriptive study of 2 cohorts. Pediatr Hematol Oncol. 2016;33:282-294. - PubMed
  30. Welsh MC, Pennington BF, Groisser DB. A normative-developmental study of executive function: a window on prefrontal function in children. Dev Neuropsychol. 1991;7:131-149. - PubMed
  31. Ventura LM, Grieco JA, Evans CL, et al. Executive functioning, academic skills, and quality of life in pediatric patients with brain tumors post-proton radiation therapy. J Neurooncol. 2018;137:119-126. - PubMed
  32. Varni JW, Seid M, Kurtin PS. PedsQL™ 4.0: reliability and validity of the Pediatric Quality of Life Inventory™ version 4.0 generic core scales in healthy and patient populations. Med Care. 2001;39:800-812. - PubMed
  33. Wechsler D. Wechsler Intelligence Scale for Children. 4th ed. San Antonio, TX: Psychological Corporation; 2003. - PubMed
  34. Wechsler D. Wechsler Intelligence Scale for Children. 5th ed. Bloomington, MN: NCS Pearson; 2014. - PubMed
  35. Wechsler D. Wechsler Abbreviated Scale of Intelligence. 2nd ed. San Antonio, TX: NCS Pearson, Inc.; 2011. - PubMed
  36. Wechsler DA. Wechsler Adult Intelligence Scale. 4th ed. San Antonio, TX: NCS Pearson; 2008. - PubMed
  37. Elliott CD. Differential Ability Scales. 2nd ed. New York, NY: Psychological Corporation; 2007. - PubMed
  38. Alfonso VC, Flanagan DP, Radwan S. The impact of the cattell-horn-carroll theory on test development and interpretation of cognitive and academic abilities. In: Flanagan DP, Harrison PL, eds. Contemporary Intellectual Assessment: Theories, Tests, and Issues. 2nd ed. New York, NY: Guilford Publications; 2005:185-202. - PubMed
  39. Keith TZ, Reynolds MR. Cattell-Horn-Carroll abilities and cognitive tests: what we've learned from 20 years of research. Psychol Sch. 2010;47:635-650. - PubMed
  40. Dumont R, Cruse CL, Price L, Whelley P. The relationship between the Differential Ability Scales (DAS) and the Wechsler Intelligence Scale for Children-third edition (WISC-III) for students with learning disabilities. Psychol Sch. 1996;33:203-209. - PubMed
  41. Kuriakose S. Concurrent validity of the WISC-IV and DAS-II in children with autism spectrum disorder. J Psychoeduc Assess. 2014;32:283-294. - PubMed
  42. Wechsler D, Raiford SE, Holdnack J. Wechsler Intelligence Scale for Children Technical and Interpretive Manual. 5th ed. Bloomington, MN: NCS Pearson. - PubMed
  43. Gioia GA, Isquith PK, Guy SC, Kenworthy L. Behavior Rating Inventory of Executive Function. Lutz, FL: Psychological Assessment Resources; 2000. - PubMed
  44. Gioia GA, Isquith PK, Guy SC, Kenworthy L. Behavior Rating Inventory of Executive Function. 2nd ed. Lutz, FL: Psychological Assessment Resources; 2015. - PubMed
  45. Baron IS. Behavior rating inventory of executive function. Child Neuropsychol. 2000;6:235-238. - PubMed
  46. McQuade JD, Tomb M, Hoza B, Waschbusch DA, Hurt EA, Vaughn AJ. Cognitive deficits and positively biased self-perceptions in children with ADHD. J Abnorm Child Psychol. 2011;39:307-319. - PubMed
  47. McCurdy MD, Turner EM, Barakat LP, et al. Discrepancies among measures of executive functioning in a subsample of young adult survivors of childhood brain tumor: associations with treatment intensity. J Int Neuropsychol Soc. 2016;22:900-910. - PubMed
  48. Carpentieri SC, Meyer EA, Delaney BL, et al. Psychosocial and behavioral functioning among pediatric brain tumor survivors. J Neurooncol. 2003;63:279-287. - PubMed
  49. Maddrey AM, Bergeron JA, Lombardo ER, et al. Neuropsychological performance and quality of life of 10 year survivors of childhood medulloblastoma. J Neurooncol. 2005;72:245-253. - PubMed
  50. Cremeens J, Eiser C, Blades M. Factors influencing agreement between child self-report and parent proxy-reports on the Pediatric Quality of Life Inventory 4.0 (PedsQL) generic core scales. Health Qual Life Outcomes. 2006;4:58. - PubMed
  51. Laffond C, Dellatolas G, Alapetite C, et al. Quality-of-life, mood and executive functioning after childhood craniopharyngioma treated with surgery and proton beam therapy. Brain Inj. 2012;26:270-281. - PubMed
  52. Modi AC, Mara CA, Schmidt M, Smith AW, Turnier L, Wade SL. Pilot executive functioning intervention in epilepsy: behavioral and quality of life outcomes. J Pediatr Psychol. 2021;46:363-374. - PubMed
  53. Grandinette S. Supporting students with brain tumors in obtaining school intervention services: the clinician's role from an educator's perspective. J Pediatr Rehabil Med. 2014;7:307-321. - PubMed
  54. Winter AL, Conklin HM, Tyc VL, et al. Executive function late effects in survivors of pediatric brain tumors and acute lymphoblastic leukemia. J Clin Exp Neuropsychol. 2014;36:818-830. - PubMed
  55. Evans SW, Owens JS, Wymbs BT, Ray AR. Evidence-based psychosocial treatments for children and adolescents with attention deficit/hyperactivity disorder. J Clin Child Adolesc Psychol. 2018;47:157-198. - PubMed
  56. Wolraich ML, Hagan JF Jr, Allan C, et al. Clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Pediatrics. 2019;144(4):e20192528. - PubMed
  57. Sonuga-Barke E, Brandeis D, Holtmann M, Cortese S. Computer-based cognitive training for ADHD: a review of current evidence. Child Adolesc Psychiatr Clin N Am. 2014;23:807-824. - PubMed
  58. Bhat S, Goodwin T, Burwinkle T, et al. Profile of daily life in children with brain tumors: an assessment of health-related quality of life. J Clin Oncol. 2005;23:5493-5500. - PubMed
  59. Tomlinson D, Tigelaar L, Hyslop S, et al. Self-report of symptoms in children with cancer younger than 8 years of age: a systematic review. Support Care Cancer. 2017;25:2663-2670. - PubMed
  60. Emser TS, Johnston BA, Steele JD, Kooij S, Thorell L, Christiansen H. Assessing ADHD symptoms in children and adults: evaluating the role of objective measures. Behav Brain Funct. 2018;14:11. - PubMed
  61. Pranckeviciene A, Deltuva VP, Tamasauskas A, Bunevicius A. Association between psychological distress, subjective cognitive complaints and objective neuropsychological functioning in brain tumor patients. Clin Neurol Neurosurg. 2017;163:18-23. - PubMed
  62. Henneghan AM, Van Dyk K, Kaufmann T, et al. Measuring self-reported cancer-related cognitive impairment: recommendations from the Cancer Neuroscience Initiative Working Group. J Natl Cancer Inst. 2021. https://doi.org/10.1093/jnci/djab027 - PubMed
  63. Gehring K, Taphoorn MJ, Sitskoorn MM, Aaronson NK. Predictors of subjective versus objective cognitive functioning in patients with stable grades II and III glioma. Neurooncol Pract. 2015;2:20-31. - PubMed
  64. Hutchinson AD, Hosking JR, Kichenadasse G, Mattiske JK, Wilson C. Objective and subjective cognitive impairment following chemotherapy for cancer: a systematic review. Cancer Treat Rev. 2012;38:926-934. - PubMed

Publication Types